Navigation Links
CME LLC Announces the Launch of the CME Activity Advances in the Management of Major Depressive Disorders
Date:1/18/2012

JERSEY CITY, N.J., Jan. 18, 2012 /PRNewswire/ -- CME LLC has officially launched an online educational activity titled "Advances in the Management of Major Depressive Disorders" on http://www.cmellc.com. Developed for psychiatrists, primary care physicians, nurses, and other health care professionals, this Case Challenge activity is intended to provide possible treatment options and individualized management approaches, including the augmentation of antidepressant therapy with folate formulations, for consideration when treating patients with major depressive disorder (MDD) in order to provide optimal patient outcomes. This activity is supported by an educational grant from Pamlab, L.L.C.

C. Brendan Montano, MD, the Director of Research at Connecticut Clinical Research, in Cromwell, Connecticut and Richard C. Shelton, MD, a James G. Blakemore Professor in the Department of Psychiatry, Professor in Departments of Psychology and Pharmacology, and Vice-Chair of Clinical Research at Vanderbilt University School of Medicine in Nashville, Tennessee comprise the faculty for the activity.

Cased-based methods of learning are extremely effective in getting across educational messages and demonstrating practical strategies. In this Case Challenge activity, participants are encouraged to determine treatment strategies based on case histories and patient presentations. "Non-response to antidepressant therapy, as defined by the presence or absence of full recovery of depression, is the rule rather than the exception for the treatment of depression, even in the primary care setting. This CME activity presents real-world examples of the management of depression to full remission. As such, I think it will provide practitioners practical strategies for managing depression to wellness." – Richard C. Shelton

Upon completion of the activity, participants should be able to:

  • Utilize evidence-based strategies to best sequence administration of antidepressant therapy with adjunctive therapies to enhance response rates and achieve remission
  • Compare and contrast the long-term efficacy, safety, and tolerability of adjunctive therapies indicated for depression to better individualize therapy
  • Understand the relationship between folate and depression, including the contribution of folate to monoamine deficiencies, to determine patient type
  • Review currently available sources of folate supplementation and their potential role in MDD management

The online activity is CME-certified and approved for nursing contact hours.  It will be available through October 31, 2012. 

About CME LLC

CME LLC develops educational plans designed to meet the needs of practicing clinicians based on demonstrated gaps within a target audience. Individual activities focus on maintaining, developing, or increasing the knowledge, skills, competence, and professional performance of clinicians to improve patient care. Founded in 1978 with the vision to provide high-quality, practical medical education and information for mental health clinicians, CME LLC's reach now expands to educational offerings for primary care, oncology, and practice management professionals in various formats including live events, print formats, interactive online activities and more.

Continuing Education Credit

CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME LLC designates this enduring activity for a 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number CEP12748 for 1 contact hour.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion, as AAPA, AANP and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Contact: Michael DeMilt
CME LLC
201.984.6224 phone
201.336.6497 fax
michael.demilt@ubm.com


'/>"/>
SOURCE CME LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the ... Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market ... Low drug registration cost in Latin American countries and ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... 25, 2017 , ... Lake Park Dental is now accepting new patients with ... Lutz, FL. With the help of this highly-effective, yet convenient system, patients can straighten ... discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and ...
(Date:4/25/2017)... ... 2017 , ... As Spring reignites vigilance against Zika virus-carrying ... Zika virus during pregnancy, as well as other prenatal exposures like cocaine, are ... The Teratology Society is an international and multidisciplinary group of scientists ...
(Date:4/25/2017)... ... ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care to ... preventative care with all my patients to alleviate possible future issues. I am pleased to ... my office and my trained staff will assist you in any way possible.” , Dr. ...
(Date:4/25/2017)... , ... April 25, 2017 , ... There is no ... Hospital, according to a special report in the May issue of Consumer Reports focused ... highest quality ranking for results achieved during and after coronary bypass and aortic valve ...
Breaking Medicine News(10 mins):